Carboplatin With or Without Atezolizumab in Treating Patients With Stage IV Triple Negative Breast Cancer

NCT03206203 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

106

Enrollment

OTHER

Sponsor class

Conditions

Triple Negative Breast Cancer
Stage IV Breast Cancer
HER2 Negative
Invasive Breast Cancer

Interventions

DRUG: Atezolizumab
DRUG: Carboplatin
OTHER: Laboratory Biomarker
OTHER: Quality-of-Life Assessment

Sponsor

Vanderbilt-Ingram Cancer Center

Collaborators

[object Object]
[object Object]